Product How it works Pricing Blog FAQ About Contact
Capricor Therapeutics

Capricor Therapeutics (NASDAQ: CAPR) revenue

Capricor Therapeutics reported revenue of $0.0m for fiscal 2025, 100.0% less than in fiscal 2024 ($22.3m).

Capricor Therapeutics's revenue has fallen for 2 years in a row, and its best year of the last 10 was fiscal 2023. The biggest drop was in fiscal 2020, −69.1%.

Revenue, in millions of US dollars4.020162.720171.720181.020190.320200.220212.6202225.2202322.320240.02025
Embed this chart

Copy this code into your website or blog. The chart updates with each new annual report.

Revenue by fiscal year

Fiscal yearRevenueChangeOperating profitOperating margin
2025$0.0m−100.0%−$108.1m—
2024$22.3m−11.5%−$42.6m−191.1%
2023$25.2m+886.8%−$24.1m−95.6%
2022$2.6m+941.8%−$29.7m−1,163.9%
2021$0.2m−21.1%−$20.9m−8,549.9%
2020$0.3m−69.1%−$13.7m−4,412.6%
2019$1.0m−39.9%−$7.7m−769.5%
2018$1.7m−37.3%−$15.3m−917.0%
2017$2.7m−33.3%−$12.9m−482.4%
2016$4.0m—−$17.0m−424.6%

The change compares each fiscal year with the one before. Operating margin is operating profit over revenue from the same filing. Figures are in millions of US dollars, except per-share amounts.

Capricor Therapeutics revenue compared with its sector

By revenue for its latest fiscal year, Capricor Therapeutics ranks 405th of the 422 US health care companies with a page on Celsmar. The sector median grew 11.7% in its latest fiscal year; Capricor Therapeutics, −100.0%.

RankCompanyRevenueRevenue growth
403rdAmylyx Pharmaceuticals$0.0m−100.0%
404thArtiva Biotherapeutics$0.0m−100.0%
405thCapricor Therapeutics$0.0m−100.0%
406thCompass Therapeutics$0.0m−100.0%
407thDenali Therapeutics$0.0m—

Each amount is in the currency the company reports in; the rank converts them to US dollars at the 16 November 2026 exchange rate. The rest are in US health care stocks.

Questions about the revenue of Capricor Therapeutics

How much revenue did Capricor Therapeutics make in fiscal 2025?
Capricor Therapeutics reported revenue of $0.0m for fiscal 2025, compared with $22.3m in fiscal 2024.
What was the best year for revenue at Capricor Therapeutics?
Of its last 10 fiscal years, fiscal 2023, with $25.2m.
Where does Capricor Therapeutics rank in its sector by revenue?
It ranks 405th of the 422 US health care companies with a page on Celsmar, by revenue for its latest fiscal year.
Where do the figures for Capricor Therapeutics come from?
From the annual report (Form 10-K) that Capricor Therapeutics files with the SEC, the US securities regulator. Each fiscal year links to its filing.

Where each figure comes from

From the annual report (Form 10-K) that Capricor Therapeutics files with the SEC. The filing for each fiscal year: 2025 · 2024 · 2023 · 2022 · 2021 · 2020 · 2019 · 2018 · 2017 · 2016. More on Capricor Therapeutics: the Capricor Therapeutics page · annual accounts · net income · insider transactions.

Information prepared from the accounts the company files with the regulator, for information purposes only. It is not financial advice or a recommendation to buy or sell. Updated on 12 November 2026.